Showing results (141-150 of 318) with videos related to

Sort By:
Pageof 32
World Journal of Gastrointestinal Oncology|April 23, 2021
Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1Ke-Ran Sun, Hui-Fang Lv, Bei-Bei Chen, et al.
Experimental and Therapeutic Medicine|June 14, 2014
Randomized controlled clinical trial of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitusYong Su, Ya-Li Su, Li-Fang Lv, et al.
Brain Research Bulletin|July 11, 2012
Essential role of NR2B-containing NMDA receptor-ERK pathway in nucleus accumbens shell in morphine-associated contextual memoryYa Xu, Xiu-Fang Lv, Cai-Lian Cui, et al.
Experimental and Therapeutic Medicine|March 27, 2014
A randomized controlled clinical trial of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitusYong Su, Ya-Li Su, Li-Fang Lv, et al.
Journal of Natural Products|December 29, 2004
Isomalabaricane-type compounds from the marine sponge Rhabdastrella aff. distinctaFang Lv, Zhiwei Deng, Jun Li, et al.
The Plant Cell|August 15, 2013
Arabidopsis histone methylase CAU1/PRMT5/SKB1 acts as an epigenetic suppressor of the calcium signaling gene CAS to mediate stomatal closure in response to extracellular calciumYan-Lei Fu, Guo-Bin Zhang, Xin-Fang Lv, et al.
BMC Veterinary Research|December 23, 2018
Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in miceJinqiu Zhang, Jinfeng Miao, Xiangan Han, et al.
Medicine|March 23, 2017
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysisXue-Li Li, Li Wang, Fang Lv, et al.
Environmental Research|December 19, 2021
Synergetic integration of catalase and Fe3O4 magnetic nanoparticles with metal organic framework for colorimetric detection of phenolJunning Wang, Minqian Zeng, Yanhong Zhao, et al.
Expert Opinion on Investigational Drugs|August 15, 2022
Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participantsZonglin Li, Chu Lin, Jinyu Zhou, et al.
Pageof 32